Synbiotic supplement for irritable bowel syndrome
Part of Digestive system clinical trials.
This trial tests whether a synbiotic (a mix of probiotics and prebiotics) called Vivatlac can improve gut health in people with moderate to severe irritable bowel syndrome (IBS). If you have IBS and are not already taking probiotics or antibiotics, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with irritable bowel syndrome (IBS) that is moderate or severe.
- You have not taken any probiotic products (like supplements or yogurts with live bacteria) in the past 3 months.
- You have not taken antibiotics in the past 3 months.
- You do not have other serious health conditions such as cancer, uncontrolled diabetes, heart, liver, or kidney problems, or a major breathing disorder.
- You do not have other bowel diseases like Crohn's disease, ulcerative colitis, or celiac disease.
- You are not pregnant, breastfeeding, or planning to become pregnant in the next 3 months.
- You do not have lactose intolerance.
- You are not taking blood thinners (anticoagulants).
- You have not taken any motility drugs or fiber supplements in the 2 weeks before the study starts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a product called Vivatlac to see if it can help people with Irritable Bowel Syndrome (IBS). If you have moderate-to-severe IBS and haven't taken probiotics or antibiotics recently, you may be able to join.
This trial is testing if a dietary supplement can reduce symptoms of irritable bowel syndrome (IBS). You might qualify if you have been diagnosed with IBS, have moderate to severe symptoms, and are between 18 and 75 years old.
This trial tests a combination of digestive enzymes and probiotics (called Enzymax DuoBiotics) to see if it can help people with irritable bowel syndrome (IBS) feel better. If you have IBS and are between 18 and 70, this study may be a good fit.
This trial tests if a dietary supplement can help people with both irritable bowel syndrome (IBS) and metabolic syndrome. It aims to improve gut health and reduce related risk factors.
This study tests whether a fecal microbiota transplant (FMT) — transferring healthy stool bacteria into your gut — can help people with severe irritable bowel syndrome (IBS) that hasn't improved after trying at least two other treatments.
This study tests a special supplement (a synbiotic with plant extracts) to see if it helps balance gut bacteria and improve IBS symptoms like bloating, belly pain, and irregular bowel habits. It lasts about 16 weeks and involves taking the supplement and providing blood and stool samples.
Hear when a new Irritable Bowel Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.